|
1
|
- Learning lessons from manufacturing industry
- Paul Downey
- Operations Director, UK Biobank
- paul.downey@ukbiobank.ac.uk
|
|
2
|
- Prof. Paul Elliott chaired a Sample Handling
and Storage development group in December 2003
- Its remit was to make recommendations on:
- Blood collection protocols
and volumes
- Transport of blood from
collection centres
- Blood processing protocols
- Archiving of fraction
aliquots
|
|
3
|
|
|
4
|
|
|
5
|
- UK Biobank is a new organisation, no legacy ANYTHING, a great
opportunity to get it RIGHT!
- Recognised Industry Errors:
- Focus on high utilisation and nominal installed capacity
- Reactive process with no control of number or quality of inputs/outputs
or constraints of the supply chain
- No standardisation of process
- Unsuitable facilities/staff (research culture)/organization structure
- Focus on point optimisation, whole process view
- On line process development and testing of b-technology
- All In-house, Why? no outsourcing or use of off the shelf components,
DIY approach
- Obsession with technology
|
|
6
|
|
|
7
|
- UK Biobank followed a characterised organisational evolution:
- Understand the difference between project and operation
- Establish the team to deliver
- Project leader
- Scientists
- Engineers
- Project managers
- Many precedents for successful project teams:
- Kelly Martin - Lockheed Martin Skunkworks
- General Groves Manhattan Project
|
|
8
|
- Understand the system and its goals and how this will deliver the
organizational objectives before investment is committed
|
|
9
|
- Base on net realisable throughput. Nominal peak component speed is
irrelevant.
- Capability: how the component must perform
- Process repeatability and tolerances
- Reliability (MTTF, MTTR, unmanned operation)
- Peak and net throughput
- Set-up and maintenance
- Redundant, de-coupled parallel cells
- Reliability of a cell based system is the sum of its parts
- Reliability of a serial system of single units system is the product of
its parts
|
|
10
|
- Recognise the complexity and point of hysteresis
|
|
11
|
- Whole system quality and in-process control
- FMEA
- Taguchi Robust design
|
|
12
|
|
|
13
|
|
|
14
|
|
|
15
|
|
|
16
|
|
|
17
|
- Poke Yoke
- Contact defects correct inputs
- Constant number defects correct processing
- Performance sequence defects correct sequence
- Error handling strategies:
- Shut out
- Attention
- Total system validation and revalidation
- Large, complex processes are prone to propagation of small errors
- SPC - Measure your process, data
driven process improvements
|
|
18
|
|
|
19
|
|
|
20
|
- The challenge:
- A fixed process (inc. outsourcing/ISO)
- New and established technologies
- New facilities
- New people
- New systems
- Transition from project to operation (often with the same staff)
- Integration with the whole process
- Statutory obligations H&S, HTA
- Managing change
|
|
21
|
- Running the process as an operation, you must implement:
- Cellular manufacturing approach
- Controlled, fully understood processes/technology
- Clear predictability/control of the supply chain
- Implement product quality process QA & QC schedule
- Proper objectives and review
- Scheduled maintenance
- New technologies/capacity developed off line (CCP)
- Proper financial control and reporting
- Focus on key measures
- Kaizen continuous improvement (vs BPR) bottom up
|
|
22
|
- Identification of optimal run time balance of throughput, batch size,
downtime, automation initialisation and lability of product
|
|
23
|
|
|
24
|
|
|
25
|
- Learn lessons from other industries
- Avoid a DIY approach; outsource
- Recognise project and operation phases
- Understand the whole system; plan for uncertainty
- Prototype and build quality into cellular processes risks fully
understood and mitigated
- Implement the appropriate culture
- Throughput and quality in a professional cellular manufacturing
environment
- Kiazen - Continuous incremental improvement (TQM)
|